Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC
New England Journal of Medicine · 25.10.2026
DOI: 10.1056/nejmoa2605703 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, online erschienen am 25.10.2026. Verfasst von Ferdinandos Skoulidis und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: F. Hoffmann-La Roche Ltd..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
- Samsung Medical Center, Seoul, South Korea.
- Department of Hematology and Medical Oncology, Emory University, Atlanta.
- Royal Marsden Hospital and Institute of Cancer Research, London.
- Department of Oncology, Asklepios Lung Clinic, German Center for Lung Research, Munich-Gauting, Germany.
- Department of Pulmonology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
ORCID-Profile: Bo Wang, Tae Min Kim
Förderung
- F. Hoffmann-La Roche Ltd.
Zitieren
APA
Skoulidis, F., Ahn, M. J., Gadgeel, S., Popat, S., Reinmuth, N., van Veggel, B., Bozorgmehr, F., Bray, V. J., Duruisseaux, M., Iams, W. T., Mazieres, J., Bonanno, L., Decoster, L., Niu, J., Pantarotto, M., Teixeira, C. H. A., Uzun, S., Wang, B., Chan, B. A., …, & Krascendo 1 Trial Investigators (2026). Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2605703
Vancouver
Skoulidis F, Ahn MJ, Gadgeel S, Popat S, Reinmuth N, van Veggel B, et al. Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2605703
BibTeX
@article{Skoulidis2026,
author = {Skoulidis, Ferdinandos and Ahn, Myung-Ju and Gadgeel, Shirish and Popat, Sanjay and Reinmuth, Niels and van Veggel, Bianca and Bozorgmehr, Farastuk and Bray, Victoria J and Duruisseaux, Michael and Iams, Wade T and Mazieres, Julien and Bonanno, Laura and Decoster, Lore and Niu, Jiaxin and Pantarotto, Marcos and Teixeira, Carlos Henrique Andrade and Uzun, Sevim and Wang, Bo and Chan, Bryan A and Felip, Enriqueta and Li, Molly S C and Akamatsu, Hiroaki and Cuppens, Kristof and Kim, Tae Min and Reck, Martin and Hu, Youyou and Shagan, Sarah M and Lin, Mark T and Osaghae, Uyi and Hoang, Tien and Wu, Felice and Meng, Raymond and Mathisen, Michael S and Solomon, Benjamin J and Krascendo 1 Trial Investigators, Krascendo 1 Trial Investigators},
title = {Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2605703}
}
EUVIMED